SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $686,472 | +1.6% | 5,663 | -4.0% | 0.00% | 0.0% |
| Q2 2023 | $675,439 | -27.1% | 5,898 | -12.3% | 0.00% | -25.0% |
| Q1 2023 | $926,769 | +20.4% | 6,724 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $769,835 | +83.7% | 5,941 | +56.8% | 0.00% | +100.0% |
| Q3 2022 | $419,000 | +61.2% | 3,788 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | -3.0% | 3,471 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $268,000 | -11.3% | 3,427 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $302,000 | -45.4% | 3,350 | -44.0% | 0.00% | -60.0% |
| Q3 2021 | $553,000 | +7.2% | 5,977 | -10.0% | 0.01% | 0.0% |
| Q2 2021 | $516,000 | +2.6% | 6,642 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $503,000 | -57.2% | 6,743 | -2.1% | 0.01% | -68.8% |
| Q4 2020 | $1,174,000 | +19.3% | 6,885 | -1.0% | 0.02% | 0.0% |
| Q3 2020 | $984,000 | -17.2% | 6,955 | -3.0% | 0.02% | -20.0% |
| Q2 2020 | $1,188,000 | +12.9% | 7,170 | -36.6% | 0.02% | -13.0% |
| Q1 2020 | $1,052,000 | -32.5% | 11,315 | -6.3% | 0.02% | -8.0% |
| Q4 2019 | $1,559,000 | – | 12,080 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |